Scientific Advances in Reconstructive Urology and Tissue Engineering

Scientific Advances in Reconstructive Urology and Tissue Engineering is a comprehensive overview of reconstructive urology that spans male and female, pediatric, neuro-urology and trauma. Traditionally, this field has been focused solely on surgical principles with little attention to basic and translational research. However, recent advances in acellular matrices, scaffolds, stem cells and tissue engineering have changed this focus. This publication is the perfect bridge and definitive tome of the advances that will move the translational and basic science of reconstructive urology forward and allow readers to implement the findings in clinical practice.

Through the use of both current case studies and future implications, the content bridges the gap from bench to bedside making it the perfect reference for translational benign urology researchers who wish to move the field of reconstructive surgery forward.

• Includes real-world applications of current research to help readers get rapidly up-to-speed on which research results are appropriate for immediate implementation
• Presents the underlying mechanism of urologic disease processes pertinent to reconstructive urology for comprehensive understanding within the field
• Provides independent guidance to manage specific clinical conditions while also presenting approaches that are applicable to all conditions

Dr. Hofer is Assistant Professor of Urology at Northwestern University Feinberg School of Medicine. He graduated magna cum laude from the University of Ulm in Ulm, Germany with both an M.D and Ph.D. and went on to complete his residency training at Northwestern University Feinberg School of Medicine. He subsequently completed a fellowship at UT Southwestern in Dallas, TX specializing in reconstruction, trauma, and prosthetics. His clinical interests include the treatment of stress urinary incontinence, which often occurs following surgery for prostate cancer. He is also an expert in the treatment of benign prostatic hyperplasia (BPH). He spent time during a postdoctoral fellowship at Harvard focusing on biomarkers of prostate cancer progression and metastasis. This included experience in clinical research, both patient-based and tissue-based, all of which he continued to implement in his research endeavors. His research efforts also include benign prostatic hyperplasia, reconstruction, and urethral wound healing.